BMC Pulmonary Medicine (Jun 2022)

Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections

  • Dulce González-Islas,
  • Carlos Sánchez-Moreno,
  • Arturo Orea-Tejeda,
  • Samantha Hernández-López,
  • Fernanda Salgado-Fernández,
  • Candace Keirns-Davis,
  • Susana Galicia-Amor,
  • Esperanza Trejo-Mellado,
  • Laura Gochicoa-Rangel,
  • Armando Castorena-Maldonado

DOI
https://doi.org/10.1186/s12890-022-02014-x
Journal volume & issue
Vol. 22, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Post-COVID-19 syndrome is characterized by diverse symptoms and abnormalities that persist beyond 12 weeks from the onset of acute COVID-19. Severity disease has been associated with more musculoskeletal alterations such as muscle weakness, dyspnea, and distance walking. The aim was to evaluate the impact of invasive mechanical ventilation (IMV) on body composition and investigate risk factors associated with sarcopenia in post-COVID-19 patients three months after moderate or severe COVID-19 infections. Methods Cross-sectional study. 530 patients with PCR-confirmed diagnoses of moderate to severe COVID-19, > 18 years old, oxygen saturation ≤ 93%, PaO2/FiO2 ratio 60 years of age, diabetes, obesity, IMV, and prolonged hospital stay. The multivariate model showed that age > 60 years (OR: 4.91, 95% CI: 2.26–10.63), obesity (OR: 3.73, 95% CI: 1.21–11.54), and interaction between prolonged length of hospital stay and IMV (OR: 2.92; 95% CI: 1.21–7.02) were related to a higher risk of sarcopenia. Conclusion Obesity and the interaction between prolonged length of hospital stay and IMV are associated with a higher risk of sarcopenia at 3 months after severe or moderate COVID-19 infection.

Keywords